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Hundreds of microRNAs (miRNAs) and endogenous small interfering RNAs (siRNAs) have been identified from both
plants and animals, yet little is known about their biochemical modes of action or biological functions. Here we report
that 29-O-methyl oligonucleotides can act as irreversible, stoichiometric inhibitors of small RNA function. We show that
a2 9-O-methyl oligonucleotide complementary to an siRNA can block mRNA cleavage in Drosophila embryo lysates and
HeLa cell S100 extracts and in cultured human HeLa cells. In Caenorhabditis elegans, injection of the 29-O-methyl
oligonucleotide complementary to the miRNA let-7 can induce a let-7 loss-of-function phenocopy. Using an
immobilized 29-O-methyl oligonucleotide, we show that the C. elegans Argonaute proteins ALG-1 and ALG-2, which
were previously implicated in let-7 function through genetic studies, are constituents of a let-7-containing protein–RNA
complex. Thus, we demonstrate that 29-O-methyl RNA oligonucleotides can provide an efficient and straightforward
way to block small RNA function in vivo and furthermore can be used to identify small RNA-associated proteins that
mediate RNA silencing pathways.
Introduction
The endoribonuclease Dicer produces two types of small
regulatory RNAs that regulate gene expression: small inter-
fering RNAs (siRNAs) and microRNAs (miRNAs) (Bernstein et
al. 2001; Grishok et al. 2001; Hutva ´gner et al. 2001; Ketting et
al. 2001; Knight and Bass 2001). In animals, siRNAs direct
target mRNA cleavage (Elbashir et al. 2001b, 2001c), whereas
miRNAs block target mRNA translation (Lee et al. 1993;
Reinhart et al. 2000; Brennecke et al. 2003; Xu et al. 2003).
Recent data suggest that both siRNAs and miRNAs incorpo-
rate into similar, perhaps even identical, protein complexes
and that a critical determinant of mRNA destruction versus
translation regulation is the degree of sequence complemen-
tary between the small RNA and its mRNA target (Hutva ´gner
and Zamore 2002; Mourelatos et al. 2002; Zeng et al. 2002;
Doench et al. 2003; Saxena et al. 2003; Zeng et al. 2003).
Target RNA cleavage directed by siRNA is called RNA
interference (RNAi). RNAi is a powerful method for the study
of gene function in animals and plants and has even been
proposed as a therapy for treating genetic disorders and viral
infections. Biochemical studies in Drosophila S2 cells (Bern-
stein et al. 2001; Hammond et al. 2001a; Caudy et al. 2002; Liu
et al. 2003) and afﬁnity puriﬁcation (Martinez et al. 2002) or
immunoprecipitation (Hutva ´gner and Zamore 2002) from
cultured human HeLa cells have identiﬁed protein compo-
nents of the RNAi effector complex, the RNA-induced
silencing complex (RISC). Genetic mutations that disrupt
RNAi in Caenorhabditis elegans, Drosophila, green algae, fungi,
and plants have likewise identiﬁed proteins required for
RNAi (Cogoni and Macino 1997, 1999a, 1999b; Ketting et al.
1999; Tabara et al. 1999, 2002; Catalanotto et al. 2000, 2002;
Dalmay et al. 2000, 2001; Fagard et al. 2000; Grishok et al.
2000; Ketting and Plasterk 2000; Mourrain et al. 2000; Wu-
Scharf et al. 2000; Grishok and Mello 2002; Tijsterman et al.
2002a, 2002b). Key steps in the RNAi pathway have also
emerged from studies of RNAi reconstituted in cell-free
extracts (Tuschl et al. 1999; Zamore et al. 2000; Hammond et
al. 2001b; Nyka ¨nen et al. 2001; Martinez et al. 2002; Schwarz et
al. 2002; Tang et al. 2003).
Recently, hundreds of miRNAs have been identiﬁed in
animals and plants (Lagos-Quintana et al. 2001, 2002; Lau et
al. 2001; Lee and Ambros 2001; Reinhart et al. 2002; Ambros
et al. 2003; Aravin et al. 2003; Brennecke and Cohen 2003;
Lim et al. 2003). Of these, the biological functions of only four
animal miRNAs are known. In C. elegans, the miRNAs lin-4
(Lee et al. 1993; Olsen and Ambros 1999) and let-7 (Reinhart
et al. 2000) regulate developmental timing, whereas the
Drosophila miRNAs bantam and miR-14 control cell survival
by repressing translation of proapoptotic genes (Brennecke
et al. 2003; Xu et al. 2003). Computational approaches
promise to identify the mRNA targets of other miRNAs
(Enright et al. 2003; Lewis et al. 2003; Stark et al. 2003), but
these proposed miRNA/target mRNA pairs will require
experimental conﬁrmation. Despite the widespread use of
RNAi to ‘‘knock down’’ gene function, the RNAi pathway
itself remains poorly understood. Similarly, despite intensive
efforts to identify all miRNAs in vertebrates, worms, and ﬂies,
the mechanisms underlying miRNA function remain myste-
rious and no biological function has been ascribed to the vast
majority of miRNAs.
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PLoS BIOLOGYHere we show that 29-O-methyl oligonucleotides are potent
and irreversible inhibitors of small RNA-directed RNA
silencing in vivo and in vitro. Our experiments using 29-O-
methyl oligonucleotides also demonstrate that the acquisition
of a target RNA by an siRNA-programmed RISC is far more
efﬁcient than the binding of an antisense oligonucleotide to
the same region of the target. To demonstrate the utility of
29-O-methyl oligonucleotides in probing RNA silencing
pathways, we show that 29-O-methyl oligonucleotides efﬁ-
ciently block siRNA-directed RISC activity in cell extracts and
in cultured human HeLa cells. When injected into C. elegans
larvae, a let-7-complementary 29-O-methyl oligonucleotide
can efﬁciently suppress lin-41 translational repression by the
let-7 miRNA. Finally, we use a tethered 29-O-methyl oligonu-
cleotide to demonstrate association of the C. elegans Argo-
naute proteins ALG-1 and ALG-2 with let-7.
Results
Inhibition of RNAi by 29-O-Methyl Oligonucleotides
Although RNAi has proved a straightforward and cost-
effective method to assess the function of protein-coding
mRNAs (Fire et al. 1998; Caplen et al. 2000, 2001; Carthew
2001; Elbashir et al. 2001a) and even some noncoding RNAs
(Liang et al. 2003), no comparable method allows the
sequence-speciﬁc inactivation of the siRNA or miRNA
components of the RISC. The ideal inhibitor of RISC
function would be a nucleic acid that would be recognized
by the RISC by nucleotide complementarity, but be refractory
to RISC-directed endonucleolytic cleavage or translational
control. In theory, such a molecule would titrate out RISCs
containing a complementary siRNA or miRNA, but not affect
the function of RISCs containing guide RNAs unrelated in
sequence. Such a RISC inhibitor should also resist degrada-
tion by cellular ribonucleases so that it persists long enough
to bind RISC and block its function. Finally, the ideal
inhibitor of small RNA function would act at concentrations
unlikely to elicit nonspeciﬁc responses to the inhibitor itself,
i.e., in the low nanomolar range, the same concentration at
which siRNAs themselves are effective.
At micromolar concentration, DNA antisense oligonucleo-
tides may block miRNA function in Drosophila embryos
(Boutla et al. 2003), but the poor stability of DNA
oligonucleotides in vivo may limit their utility. Phosphor-
othioate-substituted DNA oligonucleotides, which show good
in vivo stability, do not inhibit RISC function in vitro (data
not shown). 29-O-methyl oligonucleotides are also highly
resistant to cellular ribonucleases (Inoue et al. 1987). To test
whether 29-O-methyl oligonucleotides can act as RISC
inhibitors, we asked whether a 29-O-methyl oligonucleotide,
tethered to streptavidin paramagnetic beads via a 59 biotin
linkage, could be used to deplete siRNA-programmed RISC
from the reaction. Drosophila embryo lysate was programmed
with a synthetic siRNA duplex directed against a ﬁreﬂy
(Photinus pyralis) luciferase (Pp-luc) mRNA target (Figure 1A).
Then, a tethered 31-nt 29-O-methyl oligonucleotide comple-
mentary to the 21-nt siRNA antisense strand was added.
Finally, the beads were removed from the solution using a
magnet, and the supernatant was tested for siRNA-pro-
grammed RISC activity. Under these conditions, the 29-O-
methyl oligonucleotide completely depleted the reaction of
the RISC programmed with the antisense strand of the
siRNA, but not of RISC programmed with the sense strand
(Figure 1B). Thus, depletion occurred only when the siRNA
Figure 1. A2 9-O-Methyl RNA Oligonucleo-
tide Inhibits RNAi In Vitro in Drosophila
Embryo Lysate
(A) Sequences of the sense and antisense
Pp-luc target RNAs (black), the siRNA
( r e d ,a n t i s e n s es t r a n d ;b l a c k ,s e n s e
strand), and the sense and antisense 29-
O-methyl oligonucleotides (blue) used.
(B) Sequence-speciﬁc depletion of RNAi
activity by immobilized 29-O-methyl oli-
gonucleotides from Drosophila embryo
lysate programmed with siRNA. siRNA
was incubated with lysate to assemble
RISC; then, immobilized 29-O-methyl
oligonucleotide was added. Finally, the
beads were removed from the super-
natant, and either sense or antisense
32P-
radiolabeled target RNA was added to
the supernatant to measure RISC activity
for each siRNA strand.
Symbols and abbreviations: Ø,t a r g e t
RNA before incubation with siRNA-
programmed lysate; T, total reaction
before depletion; unbound, the super-
natant after incubation with the immo-
bilized antisense (AS) or sense (S) 29-O-
methyl oligonucleotides shown in (A).
The absence of 59 cleavage product
demonstrates that the sense oligonucleo-
tide depleted RISC containing antisense
siRNA, but not sense siRNA, and the
antisense oligonucleotide depleted the
sense RISC, but not that containing
antisense siRNA. Bi, 59 biotin attached
via a six-carbon linker.
DOI: 10.1371/journal.pbio.0020098.g001
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Inhibition of Small RNA Functionstrand contained within RISC was complementary to the
tethered oligonucleotide.
We extended this method to measure the amount of RISC
formed in the in vitro reaction at different concentrations of
the siRNA duplex. An siRNA duplex in which the antisense
strand was 59-
32P-radiolabeled was incubated in the reaction;
then, the tethered 29-O-methyl oligonucleotide was added to
deplete the reaction of antisense siRNA-programmed RISC.
The beads were then washed and the fraction of
32P-siRNA
bound to the beads determined. Depletion was veriﬁed by
testing the supernatant for RISC activity. Formally, the
amount of
32P-siRNA retained on the beads for a given
concentration of siRNA duplex places an upper limit on the
concentration of RISC formed. However, our results using
this assay are, within error, identical to the amount of RISC
measured by two independent methods: the accumulation of
single-stranded siRNA from functionally asymmetric siRNA
duplexes (Schwarz et al. 2003), and the magnitude of the burst
of target cleavage measured by pre-steady-state kinetics (B.
Haley and P. D. Zamore, unpublished data). The simplest
explanation for our results is that this assay directly measures
siRNA incorporated into RISC. Figure 2A shows the results of
this assay for six different concentrations of siRNA duplex (5
nM, 15 nM, 25 nM, 50 nM, 100 nM, and 200 nM siRNA). First,
the data show that RISC assembly in vitro is inefﬁcient; the
majority of siRNA duplexes do not contribute to RISC
production. Second, RISC assembly is saturable, suggesting
that some component of RISC itself is limiting.
To understand better the mechanism by which the 29-O-
methyl oligonucleotide interacted with RISC, we measured
the concentration of free 29-O-methyl oligonucleotide re-
quired for half-maximal inhibition of RISC activity (IC50;
Figure 2B–2G) at the six different RISC concentrations
determined in Figure 2A. The IC50 for inhibition by free 29-
O-methyl oligonucleotide is shown for each RISC concen-
tration in Figure 2H. The IC50 for the 29-O-methyl oligonu-
cleotide was remarkably close to half the RISC concentration,
suggesting that a single 31-nt 29-O-methyl oligonucleotide
binds each RISC and blocks its function. Consistent with this
apparent 1:1 stoichiometry, the data for the 29-O-methyl
oligonucleotide titrations ﬁt well to sigmoidal curves, with a
Hill coefﬁcient of 1 (Figure 2B–2G). The sequence speciﬁcity
of 29-O-methyl oligonucleotide inhibition of RISC function
clearly shows that inhibition reﬂects binding of the oligo to
the RISC. Our data are most easily explained if the
concentration of the 29-O-methyl oligonucleotide required
for inhibition in these experiments is much greater than the
KD for binding; i.e., the experiments were conducted in a
stoichiometric binding regime. Under a stoichiometric bind-
ing regime, inhibition by the 29-O-methyl oligonucleotides
would be essentially irreversible.
In theory, the 29-O-methyl oligonucleotide might act by
displacing the passenger (sense) strand of the siRNA duplex,
thereby blocking incorporation of the guide (antisense)
strand into RISC (Elbashir et al. 2001c). We can exclude this
possibility because a 59 tethered 31-nt 29-O-methyl oligonu-
cleotide complementary to the passenger strand of the siRNA
did not deplete the guide-strand RISC activity (see Figure 1B).
Similarly, an antisense sequence 29-O-methyl oligonucleotide
cannot pair with antisense RISC, but can pair with a sense
Figure 2. 29-O-Methyl Oligonucleotides
Act as Stoichiometric, Irreversible Inhibi-
tors of RISC Function
(A) The immobilized sense 29-O-methyl
oligonucleotide was used to determine
the concentration of
32P-radiolabeled
antisense siRNA assembled into RISC in
Drosophila embryo. The 29-O-methyl oli-
gonucleotide and siRNA duplex are
shown in Figure 1A.
(B–G) Inhibition of RNAi was measured
using free 29-O-methyl oligonucleotide
and 1.3 nM (B), 4.6 nM (C), 9.3 nM (D),
14.5 nM (E), 18 nM (F), and 23.5 nM (G)
RISC. The concentration of 29-O-methyl
oligonucleotide required for half-maxi-
mal inhibition (IC50) was calculated by
ﬁtting each dataset to a sigmoidal curve
using a Hill coefﬁcient of 1.
(H) A plot of IC50 versus RISC concen-
tration suggests that each 29-O-methyl
oligonucleotide binds a single RISC. The
data suggest that binding is essentially
irreversible.
DOI: 10.1371/journal.pbio.0020098.g002
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Inhibition of Small RNA Functiontarget mRNA. We anticipated that this antisense 29-O-methyl
oligonucleotide would pair with the sense target mRNA and
occlude the antisense RISC from the target. Surprisingly, the
antisense 29-O-methyl oligonucleotide was a poor inhibitor of
antisense RISC function when it was used to bind the target
site, requiring 300 nM for half-maximal inhibition in a
reaction containing 14.5 nM RISC and 3 nM sense target RNA
(Figure 3A). By contrast, the same antisense 29-O-methyl
oligonucleotide was highly effective in blocking the activity of
the sense RISC, to which it is complementary, acting with an
IC50 of 8.2 nM in a reaction containing 16.8 nM sense-strand
RISC and 3 nM antisense target RNA (Figure 3B). (In this
experiment, sense-strand RISC was generated by changing
the ﬁrst nucleotide of the sense strand from C to U, thereby
reversing its functional asymmetry [Schwarz et al. 2003].)
Thus, the interaction of 29-O-methyl oligonucleotide with
RISC is dramatically different from the interaction of 29-O-
methyl oligonucleotide with target RNA; RISC has a more
than 40-fold greater afﬁnity for the 29-O-methyl oligonucleo-
tide than the oligonucleotide has for an RNA target
(compare Figures 2E and 3A). These data imply that the
interaction of RISC with target is more complex than simple
nucleic acid hybridization. Inhibition of the siRNA-pro-
grammed RISC by a 29-O-methyl oligonucleotide with the
sequence of the target RNA is more effective than inhibition
mediated by binding of an oligonucleotide to the target RNA
itself. Thus, the RISC is more adept at ﬁnding or remaining
bound (or both) to the target RNA than a 29-O-methyl
oligonucleotide. These data suggest that speciﬁc proteins in
the RISC facilitate either target ﬁnding, target binding, or
both. Consistent with this idea, inhibition of RISC function
was incomplete using 21-nt 29-O-methyl oligonucleotides
(data not shown). Thus, target sequence ﬂanking the site of
complementarity to the siRNA guide strand may play a role
in target RISC binding. Perhaps an active mechanism that
involves target sequences ﬂanking the siRNA facilitates the
search for the target sequence; future studies will clearly be
needed to test this idea.
Figure 3. RISC Does Not Act through an
Antisense Mechanism
(A) Inhibition of sense target cleavage by
an antisense 29-O-methyl oligonucleotide
requires an approximately 40-fold higher
concentration than by a sense oligonu-
cleotide. The antisense oligonucleotide
can pair completely with the sense target
RNA, but not with the antisense siRNA-
programmed RISC. The IC50 value and
the RISC concentration are indicated.
Also shown are thesequences of thesense
Pp-luc RNA target (black), the siRNA
(red, antisense strand; black, sense
strand), and the 29-O-methyl oligonucleo-
tide (blue).
(B) The same antisense 29-O-methyl
oligonucleotide is an effective compet-
itor of antisense target cleavage. In this
experiment, inhibition occurs via bind-
ing of the antisense oligonucleotide to
the sense siRNA-programmed RISC, not
the target RNA. The IC50 value and the
RISC concentration are indicated. Also
shown are the sequences of the Pp-luc
antisense RNA target (black), the siRNA
( r e d ,a n t i s e n s es t r a n d ;b l a c k ,s e n s e
strand), and the 29-O-methyl oligonucleo-
tide (blue). The G:U wobble in the siRNA
duplex in (B) acts to direct the sense
strand into RISC and improving its
efﬁcacy in target cleavage.
DOI: 10.1371/journal.pbio.0020098.g003
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Our data show that 29-O-methyl oligonucleotides are
stoichiometric, irreversible, sequence-speciﬁc inhibitors of
siRNA function in RNAi reactions using Drosophila embryo
lysate. Can 29-O-methyl oligonucleotides block siRNA func-
tion in vivo? To address this question, we carried out
sequential transfection experiments using 1 nM, 5 nM, 10
nM, or 25 nM siRNA duplex. siRNA was transfected on the
ﬁrst day; then, reporter and control plasmids were cotrans-
fected together with various amounts of 29-O-methyl oligo-
nucleotide on the second day. Silencing of Pp-luc, relative to
the sea pansy (Renilla reniformis) luciferase (Rr-luc) control,
was measured on the third day. For each siRNA concen-
tration, we determined the concentration of 29-O-methyl
required for half-maximal inhibition of RNAi (Figure 4A–
4D). Increasing amounts of the 29-O-methyl oligonucleotide
gradually extinguished the ability of the siRNA to silence Pp-
luc in all four experiments. The inhibition of silencing in the
cultured cells cannot be a consequence of the 29-O-methyl
oligonucleotide displacing the sense strand of the siRNA
duplex, because assembly of siRNA into RISC occurred a full
day before the oligonucleotide was introduced. When 10 nM
siRNA was used in the transfection, approximately 1 nM 29-O-
methyl RNA was required for half-maximal inhibition of
RNAi (Figure 4C and 4E). At 25 nM siRNA, approximately 1.1
nM 29-O-methyl RNA was required to inhibit half the RNAi
activity (Figure 4D and 4E). In Figure 4E, we plot the siRNA
concentration versus the amount of 29-O-methyl oligonucleo-
tide required for half-maximal inhibition of silencing (IC50).
The data ﬁt well to a sigmoidal curve, consistent with the idea
that, at these concentrations, increasing amounts of siRNA do
not produce a corresponding increase in RISC activity.
Higher concentrations of siRNA were not examined because
they produce sequence-independent changes in gene ex-
pression (Persengiev et al. 2003; Semizarov et al. 2003). We
conclude that both cells and extracts have a limited capacity
to assemble RISC on exogenous siRNA. Our data suggest that
the use of siRNA concentrations greater than that required to
produce the maximum amount of RISC will lead to the
accumulation of double-stranded siRNA in vivo and may thus
contribute to the undesirable, sequence-independent re-
sponses sometimes observed in cultured mammalian cells
(Persengiev et al. 2003; Semizarov et al. 2003; Sledz et al.
2003).
Inhibition of miRNA Function In Vitro and In Vivo
In animal cells, miRNAs are thought predominantly to
function as translational regulators. Nonetheless, a growing
body of evidence suggests that they function through a
similar, if not identical, RISC as siRNAs (Hutva ´gner and
Zamore 2002; Zeng et al. 2002, 2003; Doench et al. 2003;
Khvorova et al. 2003; Schwarz et al. 2003). Because 29-O-
methyl oligonucleotides block siRNA function in vitro and
cultured human cells, we asked whether these oligonucleo-
tides might likewise disrupt the function of a speciﬁc
miRNA in vitro and in vivo. An ideal candidate for such
an miRNA is let-7. Classical genetic mutations in C. elegans let-
7 produce well-characterized, readily scored phenotypes.
Furthermore, human HeLa cells express multiple let-7 family
members, and endogenous let-7 is present naturally in RISC
(Hutva ´gner and Zamore 2002; Zeng and Cullen 2003). We
tested whether a 31-nt 29-O-methyl oligonucleotide comple-
mentary to let-7 could block target cleavage guided by the
endogenous let-7-programmed RISC present in HeLa S100
extract (Figure 5A). (Our assay detects the target-cleaving
activity of let-7; we have not examined endogenous human
mRNA targets whose translation may be repressed by let-7.)
As a control, we also tested whether the oligonucleotide
could block the activity of a let-7-containing RISC assembled
in vitro in Drosophila embryo lysate. Addition of this 29-O-
methyl oligonucleotide efﬁciently blocked target RNA
cleavage directed by the endogenous let-7-programmed RISC
in the HeLa S100 extract and by the RISC programmed with
exogenous let-7 siRNA duplex in Drosophila embryo lysate
(Figure 5C).
In addition to containing endogenous let-7-programmed
RISC, HeLa S100 can be programmed with exogenous siRNA
duplexes (Martinez et al. 2002; Schwarz et al. 2002). The target
RNA used in Figure 5B also contains sequence from the Pp-
luc mRNA and can therefore be targeted by a Pp-luc-speciﬁc
Figure 4. A2 9-O-Methyl Oligonucleotide Is a Potent Inhibitor of RNAi in
Human Cultured HeLa Cells
(A–D) HeLa cells were transfected with 1 nM (A), 5 nM (B), 10 nM (C),
or 25 nM (D) siRNA-targeting Pp-luc mRNA. The next day the cells
were cotransfected with Rr-luc-and Pp-luc-expressing plasmids
together with various amounts of a 31-nt 29-O-methyl oligonucleotide
complementary to the antisense strand of the siRNA. The half-
maximal concentration of 29-O-methyl oligonucleotide required to
inhibit (IC50) was determined by ﬁtting the data to a sigmoidal curve
using a Hill coefﬁcient of 1.
(E) IC50 plotted as a function of the concentration of transfected
siRNA.
DOI: 10.1371/journal.pbio.0020098.g004
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Inhibition of Small RNA FunctionsiRNA duplex (see Figures 1A and 5C). We incubated the Pp-
luc siRNA duplex with the human HeLa S100 to form Pp-luc-
directed RISC, then added the let-7-complementary 29-O-
methyl oligonucleotide and the target RNA. The oligonucleo-
tide blocked cleavage by the endogenous let-7-programmed
RISC, but had no effect on cleavage directed by the
exogenous Pp-luc siRNA in the same reaction (Figure 5D).
When tethered to a paramagnetic bead, this oligonucleotide
could also quantitatively deplete the let-7-programmed RISC
from the Drosophila embryo lysate (Figure 5E), demonstrating
that, again, the interaction between the 29-O-methyl oligo-
nucleotide and the RISC was apparently irreversible. The 29-
O-methyl oligonucleotide was a speciﬁc and potent inhibitor
of target cleavage directed by a naturally occurring, miRNA-
programmed RISC. Furthermore, our data demonstrate that
individual RISCs act independently even when they target the
same RNA.
Next we asked whether 29-O-methyl oligonucleotides can
inhibit miRNA function in vivo. Translational repression
directed by miRNAs occurs in C. elegans, where both the lin-4
and let-7 miRNAs have been shown to block translation of
their target mRNAs without altering mRNA stability (Wight-
man et al. 1993; Ha et al. 1996; Moss et al. 1997; Olsen and
Ambros 1999; Reinhart et al. 2000; Seggerson et al. 2002). The
genetics of lin-4 and let-7 function are well-characterized in
worms, where they are required during larval development to
control the timing and pattern of cell division in the
hypodermis (Lee et al. 1993; Reinhart et al. 2000). First, we
tested whether injection into the germline of wild-type adult
hermaphrodites of 29-O-methyl oligonucleotides complemen-
tary to either lin-4 or let-7 could block lin-4 or let-7 function
during the larval development of the resulting progeny.
Although the 29-O-methyl oligonucleotides were not toxic and
when coinjected with an unrelated DNA transformation
reporter did not prevent the uptake and expression of the
coinjected DNA, we did not observe inhibition of lin-4 or let-7
activity (data not shown). This ﬁnding suggests that single-
stranded 29-O-methyl oligonucleotides are not efﬁciently
transmitted to the progeny of injected animals. To circum-
vent this problem, we next injected 29-O-methyl oligonucleo-
tides directly into larvae and examined the phenotypes of the
injected animals. The lin-4 miRNA functions in L1/L2 larvae,
and we have found that, in our hands, L1 larvae do not
survive microinjection (data not shown); thus, it was not
possible to assay for inhibition of lin-4 function by direct
injection. In contrast, let-7 functions during the L4 stage, and
we found that L2 and L3 larvae survive the microinjection
procedure (see Materials and Methods). Loss of let-7 function
causes worms to reiterate the L4 larval molt and inappropri-
ately produce larval cuticle at the adult stage. Loss-of-
function let-7 phenotypes include weak cuticles prone to
bursting at the vulva, defects in egg-laying, and loss of adult-
speciﬁc cuticular structures that run the length of the
animal’s body, the alae (Reinhart et al. 2000). After larvae
Figure 5. A Complementary 29-O-Methyl
Oligonucleotide Blocks Endogenous let-7-
Containing RISC Function
(A) Sequence of the let-7-complementary
site in the target RNA (black), of the
siRNA (red, antisense strand; black, sense
strand), and of the let-7-complementary
29-O-methyl oligonucleotide (blue).
(B) Schematic representation of the
target RNA, which contained both Pp-
luc and antisense let-7 sequences.
(C) Drosophila embryo lysate (left) was
programmed with let-7 siRNA; then, the
target RNA and the 29-O-methyl oligo-
nucleotide were added together. Target
RNA and 29-O-methyl oligonucleotide
(right) were added to HeLa S100 extract,
which contains endogenous human let-7-
programmed RISC.
(D) An RNA target containing both Pp-
luc and antisense let-7 sequence can be
simultaneously targeted by Pp-luc siRNA
and endogenous let-7 in HeLa S100
lysate. The let-7-complementary 29-O-
methyl oligonucleotide blocks let-7-pro-
grammed, but not Pp-luc siRNA-pro-
grammed, RISC function. The bottom
panel shows the same samples analyzed
separately to better resolve the let-7 59
cleavage product.
(E) Drosophila embryo lysate was pro-
grammed with let-7 siRNA and then
incubated with biotinylated 29-O-methyl
oligonucleotide tethered to paramag-
netic streptavidin beads. The beads were
removed and the supernatant tested for
RNAi activity.
Symbols and abbreviations: Ø, target RNA before incubation with siRNA-programmed lysate; T, total reaction before depletion; unbound, the
supernatant after incubation with the paramagnetic beads. ‘‘Mock’’ indicates that no oligonucleotide was used on the beads; ‘‘let-7’’ indicates that
the beads contained the let-7-complementary oligonucleotide shown in (A).
DOI: 10.1371/journal.pbio.0020098.g005
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Inhibition of Small RNA Functionwere injected with the let-7-speciﬁc 29-O-methyl oligonucleo-
tide, 80% of the adult worms lacked alae; 77% lacked alae and
also exhibited bursting vulvae (Figure 6A). In contrast,
animals injected with an unrelated control 29-O-methyl
oligonucleotide displayed no abnormal phenotypes (Figure
6A).
All of the phenotypes associated with injection of the let-7-
complementary 29-O-methyl oligonucleotide are consistent
with a loss of let-7 activity. let-7 represses translation of lin-41
mRNA by binding to a partially complementary site in the lin-
41 39-untranslated region (Reinhart et al. 2000; Slack et al.
2000; Vella et al. 2004). Consequently, many of the pheno-
types associated with the loss of let-7 reﬂect overexpression of
LIN-41 protein; let-7 mutants are partially suppressed by
mutations in lin-41. We reasoned that if the phenotypes
observed in the injected larvae reﬂect a loss of let-7 activity,
then they should likely be partially suppressed by a lin-41
mutation (Reinhart et al. 2000; Slack et al. 2000). To test this
possibility, we injected the let-7-speciﬁc 29-O-methyl oligonu-
cleotide into the lin-41(ma104) strain and compared the
penetrance of the phenotypes with those observed for
injection into wild-type. Consistent with the idea that the
injected oligonucleotide speciﬁcally inactivates let-7,t h e
absence of alae- and vulval-bursting phenotypes were both
suppressed in the lin-41(ma104) mutant strain (Figure 6A).
The number of worms lacking alae was reduced from 80% to
16%, and worms with bursting vulvae were dramatically
reduced (74% in wild-type compared to 3.8% in the lin-
41(ma104) strain). The observed suppression (64%) was nearly
identical to that reported for a let-7, lin-41 genetic double
mutant (70%; Reinhart et al. 2000; Slack et al. 2000).
Together, our data support the idea that 29-O-methyl
oligonucleotides are potent inhibitors of miRNA function
that can be used to probe the function of speciﬁc miRNAs in
C. elegans.
Figure 6. Injection of a 29-O-Methyl
Oligonucleotide Complementary to let-7
miRNA Can Phenocopy the Loss of let-7
Function in C. elegans
(A) Wild-type and lin-41(ma104) L2-stage
C. elegans larvae were injected with either
a2 9-O-methyl oligonucleotide comple-
mentary to let-7 miRNA (Figure 5A) or an
unrelated Pp-luc 29-O-methyl oligonu-
cleotide. Absence of alae and presence
of bursting vulvae were scored when the
injected animals reached adulthood.
(B) Isolation of let-7-associated proteins
with a tethered 29-O-methyl oligonucleo-
tide. Northern blot analysis of let-7
miRNA remaining in the supernatant
of the worm lysate after incubation with
the let-7-complementary (let-7)o rPp-luc
(unrelated) oligonucleotide. Input repre-
sents the equivalent of 50% of the total
extract incubated with tethered oligonu-
cleotide.
(C) Western blot analysis of the GFP-
tagged ALG-1 and ALG-2 proteins asso-
ciated with let-7. The upper band corre-
sponds to GFP-tagged ALG-1 and the
lower to GFP-tagged ALG-2. Extracts
from a transgenic strain expressing the
tagged proteins was incubated with the
indicated tethered 29-O-methyl oligonu-
cleotide; then, the beads were washed
and bound proteins were fractionated
on an 8% SDS-polyacrylamide gel. West-
ern blots were probed using anti-GFP
monoclonal or anti-RDE-4 polyclonal
antibody. The RDE-4-speciﬁc band is
marked with an asterisk (Tabara et al.
2002).
(D and E) Analysis of let-7 miRNA in
ALG-1/ALG-2 complexes (D). Extracts
prepared from mixed-stage wild-type
worms (N2) or from GFP::ALG-1/ALG-2
transgenic worms were immunoprecipi-
tated using anti-GFP monoclonal anti-
bodies. The unbound and
immunoprecipitated RNAs were ana-
lyzed by Northern blot hybridization
for let-7 (D), and 5% of the immunopre-
cipitated protein was analyzed by West-
ern blotting for GFP to conﬁrm recovery
of the GFP-tagged ALG-1/ALG-2 pro-
teins (E).
DOI: 10.1371/journal.pbio.0020098.g006
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O-Methyl Oligonucleotide
Our in vitro experiments suggest that both siRNA- and
miRNA-containing RISCs are stably bound by 29-O-methyl
oligonucleotides. In theory, tethered 29-O-methyl oligonu-
cleotides could be used to isolate cellular factors associated
with speciﬁc miRNAs. In human cells, miRNAs such as let-7
are in a protein complex that contains Argonaute proteins
(Hutva ´gner and Zamore 2002; Mourelatos et al. 2002; Dostie
et al. 2003). In C. elegans, the Argonaute protein-encoding
genes alg-1 and alg-2 are required for the biogenesis or
function (or both) of the miRNAs lin-4 and let-7 (Grishok et al.
2001), but it has not been shown whether ALG-1 and ALG-2
proteins are directly associated with let-7.
We prepared extracts from wild-type adult worms carrying
a transgene expressing GFP-tagged ALG-1 and ALG-2
proteins. The extracts were then incubated with the let-7-
complementary 29-O-methyl oligonucleotide tethered by a 59
biotin to streptavidin-conjugated paramagnetic beads. As a
control, the experiment was performed in parallel using an
oligonucleotide not complementary to let-7. The let-7-com-
plementary, but not the control, oligonucleotide depleted
nearly all the let-7 miRNA from the extract (Figure 6B).
Western blotting using an anti-GFP antibody revealed that
both GFP-tagged ALG-1 and ALG-2 protein copuriﬁed with
the let-7-complementary oligonucleotide, but not the control
oligonucleotide (Figure 6C). In contrast, the RNA-binding
protein RDE-4, which is required for RNAi but not for
miRNA function in C. elegans, did not copuriﬁed with the let-7-
complementarity oligonucleotide, providing further support
for the speciﬁcity of the let-7:ALG-1/ALG-2 interaction
(Figure 6C).
Finally, we used a coimmunoprecipitation assay to examine
the interaction between let-7 and ALG-1/ALG-2. In this assay,
a monoclonal anti-GFP antibody was used to coimmunopre-
cipitate ALG-1/ALG-2 and small RNAs from the GFP::ALG-1/
GFP::ALG-2 strain, which expresses GFP::ALG-1/ALG-2 fu-
sion proteins. Northern blot analysis of the immune complex
showed that it contained mature 22-nt let-7 miRNA (Figure
6D). No detectable let-7 was recovered with the anti-GFP
antibody from the N2 wild-type strain. By comparing the
fraction of let-7 associated with GFP::ALG-1/ALG-2 with the
unbound fraction of let-7 miRNA, we estimate that approx-
imately 30% of the 22-nt let-7 RNAs coimmunoprecipitate
with GFP::ALG-1 and GFP::ALG-2. These data support a
model in which that ALG-1 and ALG-2 form a complex, in
vivo, that contains a substantial fraction of the mature let-7
miRNA.
Discussion
Our studies indicate that 29-O-methyl oligonucleotides
bind efﬁciently and essentially irreversibly to RISC by
basepairing with the small guide RNA. These ﬁndings provide
a rapid and reliable method to measure programmed RISC
concentration in vitro and to identify the in vivo functions of
small RNA and the identities of their associated proteins. The
ability to measure RISC concentration should enable detailed
kinetic studies of the enzymatic activity of RISC, an essential
step in understanding RISC function. In fact, this method was
recently put to use in analyzing the molecular basis of
asymmetry in siRNA function (Schwarz et al. 2003). In this
study, we have used a tethered 29-O-methyl oligonucleotide to
demonstrated the association of ALG-1/ALG-2, two C. elegans
Argonaute proteins, with the endogenous worm miRNA let-7.
Our in vitro and in vivo studies using 29-O-methyl
oligonucleotides demonstrate that cells and extracts have a
limited capacity to assemble RISC on exogenous siRNA. Our
in vitro experiments suggest that inhibition of RISC by 29-O-
methyl oligonucleotides is stoichiometric and essentially
irreversible. Using a sequential transfection protocol in
cultured cells, we ﬁnd that the half-maximal amount of 29-
O-methyl oligonucleotide required to inhibit silencing (IC50)
is less than the amount of siRNA transfected. These data
suggest that only a fraction of the transfected siRNA forms
RISC. Furthermore, the data are consistent with stoichio-
metric and irreversible binding of the 29-O-methyl oligonu-
cleotide to RISC in vivo.
O u rd a t ah i n tt h a tr e c o g n i t i o no ft h e2 9-O-methyl
oligonucleotide by RISC and, by inference, recognition of
target RNA by RISC are qualitatively different from the
simple binding of two complementary nucleic acids by
basepairing. We observed that RISC function was far more
readily inhibited by binding a 29-O-methyl oligonucleotide to
RISC than by binding the same 29-O-methyl oligonucleotide
to the site of RISC recognition on a target RNA. A clear
implication of this ﬁnding is that RISC does not acquire its
RNA target by a passive basepairing mechanism that zippers
together 21 nt of complementary RNA. Thus, RNAi is not
merely a form of antisense inhibition in which the antisense
strand is stabilized in a duplex. Rather, an active mecha-
nism—perhaps involving target sequences ﬂanking the region
of complementarity—underlies the speciﬁcity and efﬁciency
of RISC targeting.
Finally, we have shown the utility of 29-O-methyl oligonu-
cleotides to probe miRNA function in vivo. Injection of a 29-
O-methyl oligonucleotide complementary to the let-7 miRNA
into C. elegans larvae phenocopied a let-7 loss-of-function
mutation, demonstrating that 29-O-methyl oligonucleotides
can disrupt the function of a single miRNA in vivo. These
data, combined with our studies in vitro and in cultured cells,
show the promise of 29-O-methyl oligonucleotides as a tool
for dissecting the function of the numerous miRNAs found in
a wide range of organisms. In this regard, 29-O-methyl
oligonucleotides provide a tool similar in practice, but
mechanistically distinct from, RNAi itself and thus may
facilitate the study of small RNA function in cases in which
classical genetic mutations in miRNA genes are unavailable.
Materials and Methods
General methods. Drosophila embryo lysate preparation, in vitro
RNAi reactions, and cap-labeling of target RNAs were as described
elsewhere (Haley et al. 2003). Target RNAs were used at approx-
imately 3 nM concentration. Cleavage products of RNAi reactions
were analyzed by electrophoresis on 5% or 8% denaturing
polyacrylamide gels. Gels were dried, exposed to image plates, and
then scanned with a FLA-5000 phosphorimager (Fuji Photo Film
Company, Tokyo, Japan). Images were analyzed using Image Reader
FLA-5000 version 1.0 (Fuji) and Image Gauge version 3.45 (Fuji). Data
analysis was performed using Excel (Microsoft, Redmond, Washing-
ton, United States) and IgorPro 5.0 (Wavemetrics, Lake Oswego,
Oregon, United States).
siRNA and 29-O-methyl oligonucleotides. Synthetic siRNA (Dhar-
macon, Lafayette, Colorado, United States) was deprotected accord-
ing to the manufacturer, annealed (Elbashir et al. 2001b, 2001c), and
used at 50 nM ﬁnal concentration unless otherwise noted. 29-O-
methyl oligonucleotides (either from IDT, Santa Clara, California,
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GGA AUA CUU CGA AAU GUC C-39 and 59-Bio-CAU CAC GUA
CGC GGA AUA CUU CGA AAU GUC C-39 (complementary to the
Pp-luc siRNA sense strand); 59-GGA CAU UUC GAA GUA UUC CGC
GUA CGU GAU G-39 and 59-Bio-A CAU UUC GAA GUA UUC CGC
GUA CGU GAU GUU-39 (complementary to the Pp-luc antisense
strand); and 59-Bio-UCU UCA CUA UAC AAC CUA CUA CCU CAA
CCU U-39 (complementary to let-7); 59 biotin was attached via a six-
carbon spacer arm.
Immobilized 29-O-methyl oligonucleotide capture of RISC. Bio-
tinylated 29-O-methyl oligonucleotide (10 pmol) was incubated for 1 h
on ice in lysis buffer containing 2 mM DTT with 50 ll of Dynabeads
M280 (as a suspension as provided by the manufacturer; Dynal, Oslo,
Norway) to immobilize the oligonucleotide on the beads. To ensure
that the tethered oligonucleotide remained in excess when more than
50 nM siRNA was used, 20 pmol of biotinylated 29-O-methyl
oligonucleotide was immobilized. For RISC capture assays, siRNA
was preincubated in a standard 50 ll in vitro RNAi reaction for 15
min at 258C. Then, the immobilized 29-O-methyl oligonucleotide was
added to the reaction and incubation continued for 1 h at 258C. After
incubation, beads were collected using a magnetic stand (Dynal). The
unbound supernatant was recovered and an aliquot assayed for RISC
activity as previously described (Elbashir et al. 2001b; Nyka ¨nen et al.
2001) to conﬁrm that RISC depletion was complete. The beads were
then washed three times with ice-cold lysis buffer containing 0.1% (w/
v) NP-40 and 2 mM DTT, followed by a wash without NP-40. To
determine the amount of RISC formed, input and bound radio-
activity was determined by scintillation counting (Beckman Instru-
ments, Fullerton, California, United States). To isolate let-7-
containing complexes from C. elegans adults, we incubated 20 pmol
of immobilized 29-O-methyl oligonucleotide with 1 mg of total
protein.
Sequential transfection. HeLa S3 cells were transfected in a 24-well
plate (200 mm
2 per well) using Lipofectamine 2000 (GIBCO, San
Diego, California, United States) according to the manufacturer’s
protocol, ﬁrst with various concentrations of siRNA targeting Pp-luc
mRNA. After 6 h, the cells were washed with PBS and the media
replaced. On the next day, the cells were cotransfected with Rr-luc-
expressing (0.1 lg/well) and Pp-luc-expressing (0.25 lg/well) plasmids
and 29-O-methyl oligonucleotides using Lipofectamine 2000 (GIBCO)
according to the manufacturer’s protocol. The luciferase activity was
measured 24 h later with the Dual Luciferase assay kit (Promega,
Madison, Wisconsin, United States) using a Mediators Diagnostika
(Vienna, Austria) PhL luminometer.
Worm injection. For in vivo inhibition of let-7 function, 1 mg/ml let-
7-complementary 29-O-methyl oligonucleotide in water (100 lM) was
injected into either wild-type (N2) or lin-41(ma104) L2 larvae.
Injection of L2 larvae was essentially as described elsewhere (Conte
and Mello 2003). The 29-O-methyl oligonucleotide solution was
injected into the body cavity of the larvae using the low ﬂow and
pressure setting to prevent animals from dying. Despite these
precautions, approximately 60% of the animals do not survive
injection, irrespective of the oligonucleotide injected. let-7 pheno-
types were also observed at 10 lM oligonucleotide, but were less
penetrant. Phenotypes were scored after the injected animals
survived to adulthood.
Other methods. Synchronized transgenic animals carrying
GFP::ALG-1, GFP::ALG-2 were harvested at adulthood and homog-
enized in ice-cold buffer (25 mM HEPES–NaOH [pH 7.4], 150 mM
NaCl, 1 mM EDTA, 1 mM DTT, 10% [v/v] glycerol, 0.5% [v/v] Triton
X-100, 2% [v/v] SUPERaseIn [Ambion, Austin, Texas, United States])
and Mini Complete Protease Inhibitor cocktail (1 tablet/10 ml
solution) (Roche, Basel, Switzerland) using a stainless-steel Dounce
homogenizer (Wheaton Incorporated, Millville, New Jersey, United
States). The homogenized extract was clariﬁed by a centrifugation at
13,817 3 g for 10 min at 48C.
To recover the proteins associated with the let-7 miRNA, the beads
were boiled for 10 min in 20 ll of SDS loading buffer (10 mM Tris–
HCl [pH 6.8], 2% [w/v] SDS, 100 mM DTT, and 10% [v/v] glycerol).
Proteins were resolved by SDS-PAGE on an 8% gel and transferred to
Hybond-C membrane (Amersham Biosciences, Little Chalfont,
United Kingdom). To detect GFP-tagged ALG-1, ALG-2, and RDE-4
proteins, the membrane was incubated overnight at 48C with either
monoclonal anti-GFP (Roche) or an afﬁnity-puriﬁed polyclonal anti-
RDE-4 antibody (Tabara et al. 2002) diluted 1:1000 into TBST-milk
solution (100 mM Tris–HCl [pH 7.5], 150 mM NaCl, 0.1% [v/v] Tween-
20, and 5% [w/v] dried milk), incubated 1 h at room temperature with
either anti-mouse (GFP-tagged ALG-1/ALG-2) or anti-rabbit (RDE-4)
HRP-conjugated secondary antibody (Jackson Laboratory, Bar Har-
bor, Maine, United States) diluted 1:5,000 in TBST and then
visualized by enhanced chemulinescence (New England Nuclear,
Boston, Massachusetts, United States).
Immunoprecipitation of GFP-tagged ALG-1/ALG-2 complexes was
performed by preclearing worm extract with 50 ll of protein G–
agarose beads (Roche) per 5 mg of total protein for 1 h at 48C. The
cleared extract was then incubated with 10 lg of monoclonal
antibody anti-AFP 3E6 (Qbiogene, Montreal, Quebec, Canada) for 1
ha t4 8C followed by 50 ll of protein G–agarose. The agarose beads
were then washed three times with ice-cold homogenization buffer.
Depletion of let-7 miRNA was monitored by Northern blotting.
RNA was eluted from the immobilized 29-O-methyl oligonucleotide
by digestion with 1 mg/ml proteinase K in 200 mM Tris–HCl (pH 7.5),
25 mM EDTA, 300 mM NaCl, 2% (w/v) SDS at 508C for 30 min,
followed by extraction with phenol–chloroform, and recovered by
precipitation with ethanol. Recovered RNA was resuspended in 10 ll
of formamide-loading buffer (98% [v/v] deionized formamide, 10 mM
EDTA, 0.025% [w/v] xylene cyanol, 0.025 % [w/v] bromophenol blue),
heated to 1008C for 2 min. RNA was resolved on a 15% denaturing
polyacrylamide gel, transferred to Hybond-N membrane (Amersham
Biosciences), and detected by Northern blot analysis using a 59-
32P-
radiolabeled antisense let-7 RNA probe (UAU ACA ACC UAC UAC
CUC AUU) as described elsewhere (Hutva ´gner and Zamore 2002).
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